- •Quality improvement actions for drug therapy after AMI have worked sufficiently.
- •Concomitant use of the recommended drug classes 6 years after AMI was high.
- •Drug therapy was associated with hospital treatment and patients' comorbidities.
- •High polypharmacy rate in AMI survivors requires check for drug interaction.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).Eur Heart J. 2016; 37: 267-315https://doi.org/10.1093/eurheartj/ehv320
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J. 2012; 33: 2569-2619https://doi.org/10.1093/eurheartj/ehs215
- AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.Circulation. 2011; 124: 2458-2473https://doi.org/10.1161/CIR.0b013e318235eb4d
- Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes.Am J Cardiol. 2012; 109: 159-164https://doi.org/10.1016/j.amjcard.2011.08.024
- Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry.Clin Res Cardiol. 2014; 103: 655-664https://doi.org/10.1007/s00392-014-0688-0
- Long-term use of cardiovascular drugs: challenges for research and for patient care.J Am Coll Cardiol. 2015; 66: 1273-1285https://doi.org/10.1016/j.jacc.2015.07.018
- Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain.J Manag Care Pharm. 2013; 19: 247-257https://doi.org/10.18553/jmcp.2013.19.3.247
- Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries.Eur Heart J Acute Cardiovasc Care. 2013; 2: 359-370https://doi.org/10.1177/2048872613497341
- Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era.Int J Cardiol. 2006; 113: 229-235https://doi.org/10.1016/j.ijcard.2005.11.018
- 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985–2004).J Intern Med. 2008; 264: 254-264https://doi.org/10.1111/j.1365-2796.2008.01956.x
- Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction.J Am Coll Cardiol. 2000; 36: 959-969
- Variables associated with disability in male and female long-term survivors from acute myocardial infarction. Results from the MONICA/KORA Myocardial Infarction Registry.Prev Med. 2016; 88: 13-19https://doi.org/10.1016/j.ypmed.2016.03.009
- Feasibility and psychometric properties of the German 12-item WHO Disability Assessment Schedule (WHODAS 2.0) in a population-based sample of patients with myocardial infarction from the MONICA/KORA myocardial infarction registry.Popul Health Metrics. 2014; 12
- Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention.Eur J Prev Cardiol. 2015; 22: 890-899https://doi.org/10.1177/2047487314540385
- Long-term medication adherence after myocardial infarction: experience of a community.Am J Med. 2009; 122961.e7-13https://doi.org/10.1016/j.amjmed.2008.12.021
- Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.Fam Pract. 2014; 31: 688-693https://doi.org/10.1093/fampra/cmu042
- Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.Drug Saf. 2014; 37: 225-235https://doi.org/10.1007/s40264-014-0141-3
- Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.Kidney Int. 2015; 88: 396-403https://doi.org/10.1038/ki.2015.101
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.BMJ. 2015; 350h1618https://doi.org/10.1136/bmj.h1618
- Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study.Am Heart J. 2015; 170: 62-69https://doi.org/10.1016/j.ahj.2015.03.019
- Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.Arch Cardiovasc Dis. 2010; 103: 363-375https://doi.org/10.1016/j.acvd.2010.05.003
- Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes.Arch Cardiovasc Dis. 2008; 101: 301-306https://doi.org/10.1016/j.acvd.2008.04.005
- Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year.Drugs Aging. 2014; 31: 513-525https://doi.org/10.1007/s40266-014-0189-x
- Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it “ok” to discontinue?.Curr Cardiol Rev. 2012; 8: 77-84
- Effects of long-term use of cardiovascular drugs.Lancet. 2015; 385: 325https://doi.org/10.1016/S0140-6736(15)60110-6
- Angiotensin-converting enzyme inhibitor-induced angioedema—a dangerous new epidemic.Acta Derm Venereol. 2014; 94: 260-264https://doi.org/10.2340/00015555-1760
- Drug-induced diabetes mellitus: evidence for statins and other drugs affecting glucose metabolism.Clin Pharmacol Ther. 2016; 99: 390-400https://doi.org/10.1002/cpt.274
☆Conflicts of interest of all authors: none, except for CT, see COI statements.
☆Authorship: All authors had access to the data and played a role in writing the manuscript.